Evaluation the Efficacy "Think and Cope Positively" Program

Launched by UNIVERSIDAD PONTIFICIA COMILLAS · Sep 21, 2023

Keywords

ClinConnect Summary

The "Think and Cope Positively" study is looking to see if a special program can help improve the well-being of people dealing with severe mental illnesses, like schizophrenia or bipolar disorder. This program combines different types of therapy to help participants feel more positive, find purpose in their lives, and cope better with challenges. In this trial, some people will take part in 15 sessions of this program, while others will be on a waitlist and continue their usual treatment for 15 weeks. After this period, the waitlisted group will also have the chance to participate in the program.

To join the study, participants need to be adults with a clinical diagnosis of a severe mental disorder and should be stable enough to engage in the program without significant disruptions. Participants will complete assessments before and after the 15-week program, with additional follow-ups at 3 and 6 months to see how they are doing. It's important that anyone interested gets evaluated by their rehabilitation team to ensure they will benefit from the study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Users of public psychosocial rehabilitation resources belonging to the Community of Madrid and Castilla la Mancha
• • Legal age
• • Clinical diagnosis of severe mental disorder: schizophrenia spectrum, bipolar disorder, personality disorders and severe affective disorders.
• • Psychopathological stability (or that residual symptoms do not interfere with the course of treatment)
• • Minimum level of cognitive comprehension (i.e. no comorbidity with intellectual disability).
• Exclusion Criteria:
• • Addiction dependence criteria (on the other hand, people with substance abuse criteria will be accepted)
• • Altered behavior (relationally) that could alter the good functioning of the group.
• • Prior to their participation in the study, the rehabilitation team, in coordination with the research team, will assess whether the patient can benefit from the study.